Figure - available from: Biomedicines
This content is subject to copyright.
Effect of rTMS-QPI on VEP in CM-MOH patients—group level (n = 12). T1: baseline before stimulation, T2: immediately after, and T3: 3 h after one session of occipital rTMS-QPI. Panel (A): N1P1 VEP component: 1st block amplitude (above) and habituation slope (below). Panel (B): P1N2 component: 1st block amplitude (above) and habituation slope (below) (means ± SEM).
Source publication
In chronic migraine with medication overuse (CM-MOH), sensitization of visual cortices is reflected by (i) increased amplitude of stimulus-evoked responses and (ii) habituation deficit during repetitive stimulation. Both abnormalities might be mitigated by inhibitory transcranial neurostimulation. Here, we tested an inhibitory quadripulse repetitiv...
Similar publications
Introduction: Medication overuse headache (MOH) is a secondary headache that occurs 15 or more days per month in patients with preexisting headache. This can result from the excessive (10 or 15 days/month) use of drugs for acute or symptomatic headache therapy.
Aim: To examine the relationships between demographic parameters, illnesses and habits o...
We examined neurite orientation dispersion and density imaging in patients with migraine. We found that patients with medication overuse headache exhibited lower orientation dispersion than those without. Moreover, orientation dispersion in the body of the corpus callosum was statistically negatively correlated with migraine attack frequencies. The...
Introduction
Hashimoto’s thyroiditis (HT) is nowadays the leading cause of hypothyroidism with high and still growing prevalence in general population, but there are lack of data regarding migraine and HT connection.
Methods
The aim of this study was to analyze the prevalence of HT in migraine and to check if the presence of HT influence migraine...
Objective: The study aimed to evaluate the effects of monoclonal antibodies (mAbs) acting on the calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRP/R mAbs) on comorbid symptoms of depression, anxiety, and fatigue in migraine patients resistant to traditional prophylaxis. Methods: The study was an open-label prospective study assessin...
